The Food and Drug Administration yesterday authorized the first diagnostic test with a home collection option for COVID-19.

Specifically, the FDA re-issued the emergency use authorization for the Laboratory Corporation of America COVID-19 RT-PCR Test to permit testing of samples self-collected by patients at home using LabCorp’s Pixel by LabCorp COVID-19 Test home collection kit.

LabCorp said the home collection kits should be available in most states in the coming weeks to consumers with a doctor’s order.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services this week released updated fact sheets for hospitals and other types of Medicare and Medicaid providers…
Headline
Health care providers who received Provider Relief Fund and/or American Rescue Plan Rural payments exceeding $10,000 total between July 1 and Dec. 31, 2021,…
Headline
The House last night voted 220-210 to pass legislation (H.R.382) that would immediately terminate the COVID-19 public health emergency, and 227-203 to pass…
Headline
As the Congressional Telehealth Caucus considers updates to legislation that would permanently remove all geographic restrictions on Medicare telehealth…
Headline
The Biden Administration plans to end on May 11 the COVID-19 national and public health emergencies declared in 2020, according to a policy statement …
Headline
The Centers for Medicare & Medicaid Services Friday released additional guidance on changes to the Medicaid continuous enrollment requirement under…